Rheum Flashcards
1
Q
- What does rheumatology mean? Only study joints? What is very important?
- Inflammatory disease: AM stiffness? Fatigue? Activity? Sleep? Corticosteroids?
- Mechanical disease: AM stiffness? Fatigue? Activity? Sleep?
- OA: Inflammatory? Which joints? Nodes? (2) ESR? CRP?
- RA: Inflammatory? Which joints? What effected? ESR? CRP? May be related to historically?
- Gout: High levels of? Diagnosed by this? How?
A
- Study of flow; no; good H and P
- > 1 hr; yes; helps; worsens; help
- Short; no; does not help; does help
- No; weight bearing joints; Heberdens and Bouchards; negative for both
- Yes; small joints; synnovitis; positive for both; industrial revolution
- Uric acid; no; look at synovial fluid
2
Q
- Pseudogout: Synovial fluid has what in it?
- Spondyloarthropathies: Joints? Common HLA?
- SLE: Which systems? ANA? Low compliment?
- Sjorgens: Autoimmune of?
- Systemic sclerosis: Fibrosis of?
- Vasculutis: Vessel inflamm. with?
- Management? (5)
A
- Calcium pyrophosphate crystals
- Spine; HLA-B27
- Multiple; Positive; 3 and 4 low
- Exocrine gland
- Skin
- Hemmorrhaging
- NSAIDs, Gluco., DMARDS, anti TNF, MAB’s
3
Q
- ) OA: Degeneration of? Hypertrophy of?
- Often due to? Risk factors? (3)
- Joints effected? (5) Symmetrical?
- Improves with rest? Activity? Systemic?
- Bone abnormalities? (4)
- Fluid?
- 5 parts of cartilage?
- Vascular?
- Cytokines promoting damage? (3)
A
- articular cartilage; contiguous bone
- wear and tear; age, obesity, trauma
- Hip, lower lumbar, knee, DIP, PIP; no
- Yes; No; No
- Enlargement; H and B nodules, genu varus, osteophytes
- Type 1 (200-2k WBC’s) (25% PMN’s
- T2 collagen, chondrocytes, proteoglycans/hyluranic acid, MMP’s, Water
- No
- IL1 = More MMPs; TNFa=More MMPs; Complement activated
4
Q
- ) OA: Culture joints for? What to expect?
- Expected X-ray findings? (4)
- Pathogenesis: Chondrocytes can synthesize what to build? To destroy? Lower proteoglycans leads to? (3) Chondrocytes then release? (4) Causing? Adipokines? Genetics?
A
- Cell count (WBC), Crystals, Culture (gram); Type 1
- Decreased joint space, loss of cartilage, bone cysts, osteophytes
- Collagen/proteoglycans; MMP’s; Decreased hydrophiliity, loss of collagen, chondrocytes dying; IL1, TNFa, NO, PG’s = more MMP’s; Also may play a role; Possible abnormal T2 collagen
5
Q
- ) RA: Systemic? Autoimmune? Predominately in what joints? What leads to cartilage/bone destruction? Also leads to? Which is?
- Genetics associated? AM stiffness? Activity? What is often spared?
- Can lead to what systemically? (3)
- Test for what? Which is?
- Anemia?
- CRP? ESR? Synovial fluid? Mostly what cells?
- Treatment? (2)
A
- Yes; yes; peripheral, symmetric; Inflamm synovitis; Pannus (inflamed gran. tissue which then contracts)
- HLA-DR4; Yes; Helps; DIP’s
- Rheum nodules; Pleural effusions; lung fibrosis
- RF = IgM anti IgG (Fc portion)
- yes
- Both positive; inflammatory >2k; Neutro’s
- NSAIDs, DMARDS (inhibit lympho/macs)
6
Q
- ) RA: Synovial fluid compartment contains? Underinfluence of? (2) Release? (3)
- Synovial tissue: Contain? (3) Release? (3) More important in disease progression? T cells?
- Pathology: Ag+APC leads T cells to release? (2) Leads to activation of B cells which release? (2) And Macs which release? (4) Importance of RANK protein? Macs on chondrocytes?
- Anti CCP is an AB against? Specific enzyme test?
- Genetics: Which class MHC? Shared epitope? Where on ab?
A
- Neutros; IL8/TGFb; NO/PG’s/LT’s
- Macs/Lymphos/fibros; IL1/IL6/TNFa; Synovial tissue; May also play role
- IL6/IL17; RF/anti-CCP; TNFa, IL1, IL6, RANK proteins; change onsteocytes to osteoclasts; degrad enzymes
- cintrinulated (arginine) proteins; PAD
- Class 2; QKRAA; 3rd hypervariable region
7
Q
- ) Spondyloarthropathies: RF in serum? Often effects? Genetic involvement? Ligaments?
- Ankylosing Spondylitis: Often involves? Effects who most? How many months? AM? Activity? Chest expansion? Hips/shoulders?
- Labs: ESR? RF? ANA?
- X ray: Marginal? 10% have? Joint space?
- Extra acrticular involvement? (4)
- Reactive arthritis causes? Other 2 sub types?
- What did rat study show with AS?
- Treatment? (5)
A
- No; Axial skeloton; HLA-B27; enthestisis (lig inflamation)
- Sacroilliac; young males; 3 mo; Stiff; helps; may be decreased; may also be involved
- Increased; Negative; Negative
- Syndesmophytes; spinal fusion; good
- Uveitis, colitis, Cauda equana, dactilitis (sausage fingers)
- Salmonella, shigella, chlamydia, yersinella; psoriatic, colitic
- Environmental trigger is critical
- No smoking; no pillows, NSAIds, cortico, anti TNF
8
Q
- ) Spondylo:
- 4 AS theories?
- Genetics: What plays role? General pop effected? With B27? B27 plus 1 deg rel? MZ twins? 90 caucasians with disease? Genetics account for? B27? reactive arthritis?
- Reiters triad with? (3)
A
- ) Molec mimicry: B27 with same epitope leading to immune response or overlooking ag 2.) Arthrithrogenic peptide: Gut flora leaks 3.) Heavy chain thoery: Stable homodimers with no B2 microglobbulin 4.) Protein unfold: Misfolded ER leads to stress
- Class 1 B-27; 0.1-0.2; 1-2; 10-20; 60%; B27+; 60-90% HLA-B27
- With reactive arthritis: Conjuctivitis, arthritis, urethritis
9
Q
- ) SLE: Systemic disease? Common presentations? (4)
- ANA? Common ab’s? (3)
- Type 2? Type 3?
- Effects seen by type 2? (4)
- Effects seen by type 3?
- Organ specific diseases? (4)
- Epi: Men or women? Races?
- Enviromental? (2)
- Genetics? (2)
A
- Yes; Malar rash, photosensitivity, renal issues, hematologic problems
- Positive; To smith, DNA, cardiolipins
- Ab mediated, complexes
- Hemolytic anemia, anti phospholipid abs –> block clotting cascade (Higher PTT); ANA ab’s against DNA, histone, non histone; CNS involved
- Nephritis from complexes lodged
- Diabetes, good pasture, Myo gravis, Hoshimoto
- Women, AA and hispanic
- Sex hormones, Sun (dead keatinocytes)
- c4a null alleles; HLA-DR3
10
Q
- ) SLE: Patho: Misdirected?
- 6 theories?
- Treatment? (4)
- Innate involved? TLR7? TLR9? How are PMN’s implicated?
A
- Recognition of self as antigen
1. ) Loss of T cell tolerance: T cells allow self Ab’s to be switched to IgM
2. ) Polyclonal activation: LPS fires up B cells
3. ) Molec mimicry cross rxn 4.) Illicit help = foreign+ self presented 5.) Sequestered ag: Tissue damage has self exposed 6.) Immuno def. - Less sun exposure; NSAIDs/steroids; anti malarials lower humerol response; IVIG
- DNA immune complexes; RNA protein complexes from N’s Netosis (releasing DNA when dead)
11
Q
- ) Crystal Arthropathies:
- Gout: Deposition of what to urate crystals? Due to? What inflammation due to crystals? (2)
- Purine Metabolism: AMP/GMP broken down to? Then broken down to? Then? By what? Build up due to?
- 4 stages of gout and their presentation?
- Risk factors? (4)
- Active PRPP synthase or deficient HGPRT? Complete loss in?
A
- MSU (monosodium urate); hyperuricemia; articular and periarticular
- Hypoxanthine and guanine; xanthine; uric acid; xanthine oxidase; over production or lowered excretion (FAR more common)
1. ) Asymptomatic = MSU > 7mg/dl
2. ) Acute: Podagra MTP flare up
3. ) Intercritical: Asymptomatic intervals
4. ) Chronic: Tophi = crytals in soft tissue/joints; often in digits, olecranon bursa and achilles - obesity, insulin reisistance, htx, dehydration
- Increased Uric acid/ Lesch-Nyhan
12
Q
- ) Crystal arthropathies:
- Gout mechanism: Triggers? (4) Crytals interact with synovial lining leading to? Picked up by which TLR’s? Leads to release of? (3) NLRP3 in cell cleaves? Leads to?
- Secondary hyperurucemia due to? What is activated? Which is?
- Gout: Inflammatory fluid? Crytals? (2)
- Pseudogout: Inflammatory? Crystals? (2) Due to overabundance of? Via what gene? Crystals released by? Not in what like gout? First MTP?
A
- Low temp, trauma, low Ph, dehydration; activation of mono/macs; TLR2/4; TNFa, IL6, IL8; IL1B; bringing in more macs
- Drugs lower renal excretion; URAT1; urate organic anion exchanger in proximal tubules
- Yes; needle shaped; neg. byfringence
- Yes; rhomboid + byfringence; PPi; ANKH gene; CPPD crystals released by shedding; not formed in synovial fluid; rarely effected
13
Q
- ) Vasculitis:
- Large vessel: a.) Giant Cell: Where? (2) Effects? Common genetic?
b. ) Takayasu’s: Effects? Upper? Granulomatous? - ) Medium Vessel: a.) PN effects? (3)
b. ) Kawasaki: Effect who? Damage by? - ) Small Vessel: ANCA positives? (3) Distinct feature? Feature to all three?
b. ) ANCA negatives? Unique feature?
A
a. ) Temporal, eyes; internal elastic lamini; HLA-DR4
b. ) Aortic arch; no, lower; yes
a. ) skin, bifurcation, kidneys
b. ) Kids; cytokine mediated
1. ) GPA = C-ANCA
2. ) Churg Strauss: Eisinophil involvement
3. ) MPA = P-ANCA
* ENT, Lungs, Kidneys
1. ) HSP = IgA
2. ) ECV = Cyroglobins (hep c)
3. ) CLA = Immune complexes
14
Q
- ) Vasculitis:
- Clinical features? (2)
- ESR? CRP? Compliment? Albumin?
- Mechanisms: IC? ANCA? Antiendothelial via? (2) T cell endothelial injury via? Endothelial infection?
- Types of ANCA’s? Where? Bind? Effect?
- Treatment? (2)
- Mechanism? (6)
- Cause immune complexes? (4)
A
- Palpable purpura, systemic symptoms
- High; High; Low; Low
- Yes; Yes; ADCC and compliment; HLA-DR4; MHC Class 2
- C = cytoplasmic = PR3 on neutrophils primary granules
- P = perinuclear; binds MPO
- Both amplify immune response
- Glucocoticoids, Ritixumab
- Inflamation –> PAF –> Incr. vasc perm –> IC deposition –> Complement –> PP
- Bugs, drugs, malignancy, connective tissue disorders
15
Q
- ) PS/DS:
- Type: 1? 2? 3? 4? 5?
- Clinical findings? (7)
- Most important extra muscular finding?
- Markers of disease: Anti-JO-1 and? Leads to? (4)
- Labs: CPK? Myoglobin? AST? ALT? ESR? ANA?
- EMG: Distinct how? (3)
A
- ) PM 2.) DM 3.) PM/DM with neoplasia 4.) Childhood DM 5.) PM/DM with another connective tissue disorder
- proximal muscle weakness; Gottmans papules; heliotrope rash; V sign, Shawl sign, mechanics hands, preiungal erythema
- Lung disease
- Anti-histatydyl tRNA; fever, arthritis, lung, vasculitis
- High, high, high, high, high, ANA positive
- Low amplitude, fibrillations, irreg spiking